|
RBM14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.051980E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.390700E-04 |
| Normal-vs-Stage2 |
1.388400E-01 |
| Normal-vs-Stage3 |
4.641900E-02 |
| Normal-vs-Stage4 |
2.184500E-02 |
| Stage1-vs-Stage2 |
3.170200E-01 |
| Stage1-vs-Stage3 |
4.475600E-01 |
| Stage1-vs-Stage4 |
8.032000E-01 |
| Stage2-vs-Stage3 |
7.779200E-01 |
| Stage2-vs-Stage4 |
2.860400E-01 |
| Stage3-vs-Stage4 |
4.652400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.861610E-02 |
| Normal-vs-AfricanAmerican |
3.439800E-03 |
| Normal-vs-Asian |
1.979420E-01 |
| Caucasian-vs-AfricanAmerican |
4.435800E-01 |
| Caucasian-vs-Asian |
8.375600E-01 |
| AfricanAmerican-vs-Asian |
9.497000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.244870E-03 |
| Normal-vs-Female |
4.512800E-01 |
| Male-vs-Female |
1.216200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.026400E-02 |
| Normal-vs-Extreme_Weight |
1.416180E-03 |
| Normal-vs-Obese |
6.462400E-02 |
| Normal-vs-Extreme_Obese |
1.128320E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.980190E-01 |
| Normal_Weight-vs-Obese |
7.578200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.447000E-01 |
| Extreme_Weight-vs-Obese |
6.572500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.453200E-01 |
| Obese-vs-Extreme_Obese |
1.379790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.218400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.848000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.943310E-03 |
| Normal-vs-Age(81-100Yrs) |
1.043890E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.766800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.520200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.202100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.528150E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.909700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.034800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.896000E-02 |
| Normal-VS-Type2 PRCC |
1.73350000000072E-05 |
| Normal-VS-KIRP CIMP |
2.987400E-01 |
| Normal-VS-Unclassified PRCC |
2.175000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.406300E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.353800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.817000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.904200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.716900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.804000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.395500E-04 |
| Normal-vs-N1 |
4.761400E-01 |
| Normal-vs-N2 |
1.729810E-01 |
| N0-vs-N1 |
8.782200E-02 |
| N0-vs-N2 |
9.897200E-01 |
| N1-vs-N2 |
4.532600E-01 |
|
|
